Erysipelothrix rhusiopathiae septic arthritis.
We describe herein the case of a man with Erysipelothrix rhusiopathiae septic arthritis and possible infective endocarditis. This is the first report in the English-language medical literature of septic arthritis caused by this organism.
Ruiz
Maria E
ME
FDA, Rockville, Maryland, USA. ruizm@cder.fda.gov
Richards
J Steuart
JS
Kerr
Gail S
GS
Kan
Virginia L
VL
D000368:Aged; D001170:Arthritis, Infectious / Q000382:microbiology / Q000473:pathology* / Q000628:therapy; D001182:Arthroscopy; D003131:Combined Modality Therapy; D004697:Endocarditis, Bacterial / Q000150:complications / Q000473:pathology* / Q000628:therapy; D004888:Erysipelothrix / Q000302:isolation & purification* / Q000472:pathogenicity; D004889:Erysipelothrix Infections / Q000150:complications / Q000473:pathology* / Q000628:therapy; D006801:Humans; D008297:Male; D019152:Paracentesis; D010400:Penicillin G / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D016896:Treatment Outcome
D010406:Penicillins; D010400:Penicillin G